tiprankstipranks
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market

InnoCare Pharma Ltd. (9969) Income Statement

Compare
1 Followers

InnoCare Pharma Ltd. Income Statement

Last quarter (Q2 2024), InnoCare Pharma Ltd.'s total revenue was ¥253.91M, an increase of 34.94% from the same quarter last year. In Q2, InnoCare Pharma Ltd.'s net income was ¥―. See InnoCare Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 738.54M¥ 625.40M¥ 1.04B¥ 1.36M¥ 1.25M
Gross Profit
¥ 610.10M¥ 482.01M¥ 977.37M¥ 1.36M¥ 1.25M
Operating Expenses
¥ 1.26B¥ 1.21B¥ 1.14B¥ 495.91M¥ 251.88M
Depreciation and Amortization
¥ 92.62M¥ 68.40M¥ 33.71M¥ 11.45M¥ 9.07M
EBITDA
¥ -516.55M¥ -808.28M¥ 16.23M¥ -453.44M¥ -2.14B
Operating Income
¥ -651.15M¥ -891.63M¥ -24.25M¥ -464.89M¥ -2.15B
Other Income/Expenses
¥ 6.95M¥ -525.11K¥ 146.12M¥ 73.03M¥ -1.90B
Pretax Income
¥ -644.21M¥ -893.73M¥ -20.12M¥ -464.26M¥ -2.15B
Net Income
¥ -631.26M¥ -871.65M¥ -66.68M¥ -463.17M¥ -2.14B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -0.37¥ -0.59¥ -0.05¥ -0.48¥ -1.71
Diluted EPS
¥ -0.37¥ -0.59¥ -0.05¥ -0.48¥ -1.71
Weighted Average Shares Outstanding
1.71B 1.48B 1.37B 967.58M 1.25B
Weighted Average Shares Outstanding (Diluted)
1.71B 1.48B 1.37B 967.58M 1.25B
Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis